TTop stories Read More FDA rejects Regenxbio’s MPS II rare-disease gene therapyFebruary 10, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Novo Nordisk sues Hims & Hers over compounded obesity drugsFebruary 9, 2026 Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper,…
TTop stories Read More TrumpRx promises cheapest drugs. Many cost less alreadyFebruary 8, 2026 WASHINGTON — President Trump said his administration’s new TrumpRx website will offer the cheapest prices in the world…
TTop stories Read More White House launches direct to consumer drug siteFebruary 5, 2026 President Donald Trump makes an announcement from the Oval Office at the White House in Washington, Nov. 6,…
TTop stories Read More Eli Lilly (LLY) earnings Q4 2025February 4, 2026 Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand…
TTop stories Read More Pfizer (PFE) earnings Q4 2025February 3, 2026 Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while…
TTop stories Read More Why a week without blockbuster M&A was actually fantasticJanuary 16, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Childhood vaccine schedule slashed, ‘unknown risks’ of vaccination citedJanuary 6, 2026 WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response to an…
TTop stories Read More 2025 FDA approvalsJanuary 3, 2026 Drug developers secured approvals for 46 new therapeutic agents from the FDA’s Center for Drug Evaluation and Research…
HHeadlines Read More Pill version of Novo Nordisk’s Wegovy approved, possibly widening accessDecember 23, 2025 The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug…
HHeadlines Read More Trump reclassifies cannabis to Schedule III, easing weed restrictionsDecember 19, 2025 U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in…
TTop stories Read More Eli Lilly’s weight loss drug retatrutide clears first late-stage studyDecember 11, 2025 The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…